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Abstract 
Background: Campylobacter jejuni (C. jejuni) has been assigned as an important food-borne pathogen for human 
health but many pathogenicity factors of C. jejuni and human host cell responses related to the infection have not yet 
been adequately clarified. This study aimed to determine further C. jejuni pathogenicity factors and virulence genes 
based on a random mutagenesis approach. A transposon mutant library of C. jejuni NCTC 11168 was constructed and 
the ability of individual mutants to adhere to and invade human intestinal epithelial cells was evaluated compared to 
the wild type. We identified two mutants of C. jejuni possessing altered phenotypes with transposon insertions in the 
genes Cj1492c and Cj1507c. Cj1492c is annotated as a two-component sensor and Cj1507c is described as a regula-
tory protein. However, functions of both mutated genes are not clarified so far.
Results: In comparison to the wild type, Cj::1492c and Cj::1507c showed around 70–80% relative motility and 
Cj::1492c had around 3-times enhanced adhesion and invasion rates whereas Cj::1507c had significantly impaired 
adhesive and invasive capability. Moreover, Cj::1492c had a longer lag phase and slower growth rate while Cj::1507c 
showed similar growth compared to the wild type. Between 5 and 24 h post infection, more than 60% of the intracel-
lular wild type C. jejuni were eliminated in HT-29/B6 cells, however, significantly fewer mutants were able to survive 
intracellularly. Nevertheless, no difference in host cell viability and induction of the pro-inflammatory chemokine IL-8 
were determined between both mutants and the wild type.
Conclusion: We conclude that genes regulated by Cj1507c have an impact on efficient adhesion, invasion and 
intracellular survival of C. jejuni in HT-29/B6 cells. Furthermore, potential signal sensing by Cj1492c seems to lead to 
limiting attachment and hence internalisation of C. jejuni. However, as the intracellular survival capacities are reduced, 
we suggest that signal sensing by Cj1492c impacts several processes related to pathogenicity of C. jejuni.
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Background
Campylobacter spp. are microaerophilic, gram-negative 
and motile bacteria belonging to the family of Campy-
lobacteraceae [1]. C. jejuni is the most frequent cause of 
bacterial food borne disease worldwide [2–4]. The most 
common symptoms caused by C. jejuni are gastroen-
teritis usually accompanied by fever, vomiting, abdomi-
nal pain and bloody diarrhoea [1, 5]. In contrast to other 
enteropathogens, our understanding of pathogenetic 
mechanisms of C. jejuni lags behind and functions of 
many genes of C. jejuni still remain to be elucidated.
In the course of colonisation, C. jejuni can cross the 
mucosal barrier, adhere to as well as invade host epi-
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6]. Extensive studies have investigated that C. jejuni 
possesses numerous pathogenicity-associated factors 
involved in bacterial colonisation, transmigration and 
intracellular survival in intestinal epithelial cells [7, 8]. 
Two major known transmigration mechanisms are the 
transcellular and the paracellular pathway [8]. The trans-
cellular route allows C. jejuni to cross the epithelial layer 
by attaching and invading at their apical surface, followed 
by escaping at the basolateral membrane. The paracellu-
lar pathway is characterised by breaking the tight junc-
tion and adherens junction complexes and crossing 
epithelial barriers by passage between neighbouring cells 
[7]. It has been demonstrated recently, that the C. jejuni 
protease HtrA is involved in breaching the epithelial bar-
rier and enables invasion of epithelial cells via the para-
cellular pathway [9].
Hence, adhesion and invasion are recognised as impor-
tant features in C. jejuni pathogenesis [10, 11]. There 
are several adhesion and invasion related genes already 
characterised in many in  vivo and in  vitro studies. The 
flaA and flaB genes, encoding major flagellin proteins, 
are strongly associated with invasiveness of C. jejuni [1]. 
Other genes such as cadF have been also implicated in 
adhesion. It is involved in the synthesis of a fibronectin-
binding outer membrane protein facilitating attachment 
to glycoproteins of epithelial cells [12]. Mutagenesis 
based experiments indicate that several other genes, for 
example ciaB, capA and flgB are involved in binding and 
invasion of host intestinal epithelial cells [1, 5].
Campylobacter jejuni infection can induce the expres-
sion of various cytokines [13–15]. Interleukin-8 (IL-8) 
is an important pro-inflammatory chemokine of intes-
tinal epithelial cells and acts as a chemotactic factor 
of immune cells. It can be induced during infection by 
adhesion and/or invasion as well as exposure to the 
cytolethal-distending-toxin (CDT) produced by C. jejuni 
[13, 14, 16, 17]. While research in the past decade has 
focused on mechanisms of C. jejuni interaction with host 
cells, the knowledge on its intracellular fate is still lim-
ited. Only few genes have been reported to be involved in 
intracellular survival of C. jejuni [18].
Studies have proved that the intestinal mucosa behaves 
as the first barrier against microbial infections. Since 
human intestinal epithelial cells are polarised and possess 
a luminal mucous layer [7], adhesion, invasion and trans-
location ability of C. jejuni have been shown to depend 
on these characteristics. In our study, we have used the 
epithelial cell line HT-29/B6, a sub clone of HT-29 cell 
line, which has been shown to produce a mucus layer [19] 
providing an appropriate model for C. jejuni interaction.
In this study, we applied an approach utilising in vitro 
integration of a transposon in C. jejuni genomic DNA fol-
lowed by natural transformation [20, 21]. A transposon 
mutant library was constructed in C. jejuni NCTC 
11168, from which two mutants with altered capabil-
ity to invade human intestinal epithelial cells have been 
selected and used for further phenotypical characterisa-
tion. The aim of the present study was to discover hith-
erto unknown pathogenicity factors of C. jejuni with 
respect to adhesion, invasion, intracellular survival and 
host cell response. We found that mutagenesis of Cj1492c 
and Cj1507c, two so far poorly characterised genes of C. 
jejuni NCTC 11168, has remarkable effects on adhesion 
and invasion of host cells in a reverse manner. However, 
they seem not to influence host cell pro-inflammatory 
responses.
Results
Transposon mutagenesis of C. jejuni NCTC11168
In this study, the HyperMu <KAN-1> Transposon was 
randomly inserted into the DNA of C. jejuni NCTC 
11168 using a 2 h in vitro reaction catalysed by HyperMu 
MuA Transposase and subsequently transformed into C. 
jejuni NCTC 11168 by natural competence. This in vivo 
protocol successfully generated 24 kanamycin-resistant 
mutants in C. jejuni NCTC11168. Transposon inser-
tion site was determined by sequencing with the prim-
ers included in the HyperMu <KAN> Transposon Kit and 
verified by gene specific PCR amplification. The sequence 
data proved that each mutant had a single transposon 
insertion and transposons were inserted randomly on C. 
jejuni chromosome (data not shown). To identify genes 
involved in C. jejuni pathogenicity, the obtained mutants 
were subsequently screened using invasion assays with 
HT-29/B6 cells. Two mutants (::Cj1492c and ::Cj1507c) 
that showed differing invasiveness compared to the wild 
type were chosen to assess detailed phenotypic studies. 
However, the function of mutated genes is not clarified so 
far. One insertion is located in the gene Cj1492c, anno-
tated as a two-component sensor and the second one is 
located in the gene Cj1507c, described as a regulatory 
protein, involved in molybdenum and tungsten transport 
[22]. The maps of Cj1492c and Cj1507c genes and trans-
poson insertion sites are shown in Fig. 1a, b. The results 
of a gene specific PCR are shown in Fig. 1c. Both mutants 
possessed an approximately 1.2 kb larger fragment com-
pared to the parental target DNA indicating that these 
genes contained a transposon insertion.
Growth dynamics
Both mutants (::Cj1492c and ::Cj1507c) and the wild 
type were separately inoculated in Brucella broth (BB) 
and incubated for 48  h at 37 ℃ under microaerobic 
conditions and viable cell counts were determined over 
time. A growth curve including lag (0–8 h), exponential 
(8–18 h) and stationary (18–32 h) phases is presented 
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in Fig.  1d. Strain ::Cj1507c grew almost identically to 
the wild type whereas ::Cj1492c showed apparent dif-
ferences in growth dynamics. Early growth rate of 
::Cj1492c was clearly retarded compared to the wild 
type as represented by a flatter slope of the growth 
curve between 6 and 18  h and approx. 100-fold lower 
number of viable bacteria during exponential phase. 
After 28  h, ::Cj1492c reached a stationary phase with 
significantly diminished number of viable bacteria 
compared to the wild type and ::Cj1507c and there was 
no difference between the two other strains.
Swarming ability of ::Cj1492c and ::Cj1507c
As motility is essential for host invasion [1, 18], ::Cj1492c, 
::Cj1507c, wild type and a ::flaA mutant (used as a 
negative control) were tested on semisolid Mueller–
Hinton agar (MH) plates to examine whether C. jejuni 
swarming ability is affected in the mutated strains. 
Swarming ability of the three mutants was normalised to 
the wild type. As expected, ::flaA was found to be barely 
motile (36%), which is consistent with previous studies [1, 
23–25]. In contrast and as shown in Fig. 1e, both mutant 
::Cj1492c and ::Cj1507c, showed slightly reduced swarm-
ing ability (approx. 73% and 82% of wild type swarming 
in MH, respectively).
Adhesion and invasion of human intestinal epithelial cells 
by ::Cj1492c and ::Cj1507c
Both mutants along with the wild type were tested for 
their abilities to adhere to and invade HT-29/B6 host 
Fig. 1 Genomic locus, transposon insertion sites in C. jejuni NCTC 11168 mutants ::Cj1492c and ::Cj1507c and PCR verification of both mutants and 
phenotypic analyses of two mutants. a, b Genes are plotted as arrows in order to their genomic locations. Boxed arrows length indicates relative 
gene sizes. a The location of inserted transposon is indicated in C. jejuni two-component sensor gene (Cj1492c). b The location of the inserted 
transposon is indicated in C. jejuni regulatory protein gene (Cj1507c). c Agarose gel electrophoresis of genomic DNA of mutants ::Cj1492c, ::Cj1507c 
and wild type using gene specific primers. With integration of the transposon (1219 base pairs) the DNA fragment sizes of both mutants are 
around 1400 base pairs in length which are 1.2 kb larger than the target DNA of the wild type (around 200 base pairs). d Growth curve of wild type, 
::Cj1492c and ::Cj1507c were assessed by CFU counting. Values are shown as mean value of three independent experiments. Error bars represent SD. 
Statistical comparison with the wild type: *p ≤ 0.05, unpaired t-test. e Differential swarming ability of mutated strains was normalised with the wild 
type strain and is presented as percentage of swarming halos of wild type (100%). Columns show median value of five biological replicates and bars 
indicate maximum and minimum range. *p ≤ 0.05; ***p ≤ 0.001; ****p ≤ 0.0001, unpaired t-test
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cells. Therefore, HT-29/B6 monolayers (with approx. 
80–90% confluence) were infected with approx. 1 × 109 
colony-forming units (CFU) of each strain. The strain 
::Cj1492c showed more than threefold but statistically 
not significantly enhanced adhesion to HT-29/B6 cells 
compared to the wild type (0.037% of ::Cj1492c vs. 
0.011% of wild type inoculum adhered to host cells). 
However, disruption of Cj1507c caused clearly and sig-
nificantly (p ≤ 0.05) decreased adhesion to host cells. 
Only 0.003% of ::Cj1507c inoculum adhered to HT-29/
B6, which corresponds to 27% of the wild type (Fig. 2a).
In accordance with the adhesion analysis, we deter-
mined that mutant ::Cj1492c invaded epithelial cells 
approx. 3-times more efficiently than the wild type 
(0.0049% of inoculum for ::Cj1492c vs. 0.0015% for wild 
type, p ≤ 0.001), while the strain ::Cj1507c showed ten-
fold reduced (p ≤ 0.05) ability to invade HT-29/B6 cells 
compared to the wild type (Fig. 2b).
Immunodetection of intracellular C. jejuni
With regard to adhesion and invasion, we examined 
that mutation of the genes Cj1492c and Cj1507 causes 
contrary phenotypes. In order to determine the inter-
nalisation level of C. jejuni in HT-29/B6, immunofluo-
rescence staining along with WGA and DAPI staining 
were performed up to 5 h post infection (p.i.). WGA is 
a carbohydrate-binding lectin that has high affinity for 
sialic acid and N-acetylglucosamine [26] and is used 
Fig. 2 Adhesion, invasion and internalisation levels of C. jejuni in HT-29/B6 cells and immunofluorescent detection of intracellular C. jejuni. Adhesion 
(a) of three tested strains to HT-29/B6 was detected at 1 h p.i.. For determination of invasion (b), the monolayer of HT-29/B6 was incubated with 
gentamicin for an additional 2 h prior to lysis. Experiments were performed at least three independent times in triplicate. The relative adhesion 
and invasion index were normalised with wild type and are presented as percentage of the adhesion and invasion index of wild type, respectively. 
Results show the mean value ± SD. *p ≤ 0.05; ***p ≤ 0.001, unpaired t-test. c HT-29/B6 cells and immunofluorescently labelled wild type, ::Cj1492c 
and ::Cj1507c (green, indicated by white arrows) and untreated control cells are shown at 5 h p.i. Cell cytoplasm membrane were stained with 
WGA-CF®594 (red) and nuclei with DAPI (blue). Scale bars indicates 25 μm. d The internalisation level of C. jejuni by HT-29/B6 was determined as a 
ratio of particles of invaded C. jejuni and infected cells by means of immunofluorescence microscopy and automatic particle counting using ImageJ. 
The relative level of internalisation was normalised with wild type and is presented as percentage of the wild type. Fluorescent particles of each 
strain were quantified in at least six microphotographs selected randomly for each biological replication and results are presented for four individual 
experiments. Asterisks show statistically significant differences between ::Cj1492c and ::Cj1507c. *p ≤ 0.05; unpaired t-test
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as a marker for the cytoplasm membrane of host cells. 
To subtract unspecific immunofluorescent signal, non-
infected HT-29/B6 cells, which were stained the same 
as the infected samples, were used as a negative con-
trol. There was no immunofluorescent signal detected 
in the negative controls. As representatively shown in 
Fig.  2c, several bacteria seemed to be located at the 
intercellular spaces. No specific differences were found 
among the tested strains. Furthermore, we quantified 
the number of invaded bacteria per host cell at 5 h p.i. 
by means of fluorescent particle counting using ImageJ 
[27, 28]. The average number of wild type C. jejuni per 
host cell was ~ 0.08 bacteria/host cell. As shown in 
Fig.  2d, the mutant ::Cj1492c exhibited increased lev-
els of internalisation compared to the wild type (181% 
of the wild type) but was not statistically significant, 
whereas ::Cj1507c possessed half the internalisation of 
the wild type (47% of the wild type, p  ≤ 0.05). These 
data are in line with our observations in the invasion 
assay shown above.
Intracellular persistence of the mutants ::Cj1492c 
and ::Cj1507c
We were able to show that these two mutants possess 
adhesion and invasion capabilities in a reverse manner 
but retain only slightly diminished swarming abilities 
compared to the wild type. Furthermore, we wanted to 
address whether both mutants showed altered abilities to 
persist intracellularly. Therefore, the number of intracel-
lular bacteria was determined over time by examining the 
CFU at 5 and 24 h p.i., respectively. More than two-thirds 
of the intracellular wild type C. jejuni were eliminated 
between 5 and 24  h p.i. while approx. 85% of intracel-
lular ::Cj1492c and more than 95% of the intracellular 
::Cj1507c were eliminated within this time. As indicated 
in Fig. 3a, the mutant ::Cj1492c exhibited half the survival 
rate of the wild type (48.1% of wild type, p ≤ 0.05) and the 
intracellular persistence of strain ::Cj1507c was only one-
tenth of the wild type (9.4% of wild type, p ≤ 0.01). Both 
mutants showed significantly diminished intracellular 
survival rates compared to the wild type. However, there 
was no statistically significant difference between the 
mutants. Regardless of the mutation, these data showed 
that most intracellular C. jejuni were killed within the ini-
tial 24 h p.i. in HT-29/B6.
Effects of mutations on host cell viability
For determining effects of C. jejuni strains on host cell 
survival, we tested the viability of HT-29/B6 cells at 5 
and 24 h p.i. based on Calcein-AM/Hoechst staining [29, 
30]. This assay quantitatively determines the number of 
viable host cells indicated by the Calcein signal versus the 
total counts of cells represented by Hoechst staining. To 
assess relative host cell survival after infection, the ratio 
of viable to total cell numbers was calculated in relation 
to non-infected cells. As shown in Fig. 3b, there was no 
significant difference in host cell viability among tested 
stains and for the duration of the experiment over 24 h.
Cytokine induction by C. jejuni mutants in HT‑29/B6 cells
To assess the effects of mutations on the induction of 
pro-inflammatory cytokines, the mRNA expression 
of IL-8 and IL-6 was evaluated by calculating the rela-
tive fold difference to non-infected cells (controls). The 
results (Fig. 3c) indicated that all strains uniformly induce 
IL-8 mRNA expression of host cells at 1 h p.i. followed by 
Fig. 3 Intracellular survival of C. jejuni, relative viability of HT-29/B6 
cells and RT-qPCR analysis of IL-6 and IL-8 mRNA expression in HT-29/
B6 cells after C. jejuni infection. a Intracellular survival, presented as 
CFU recovery rates of intracellular viable cell counts, was determined 
as a ratio of viable counts between 5 and 24 h p.i. The relative 
survival rate was normalised with the wild type and is presented as 
percentage of the wild type. Results represent at least six individual 
experiments and asterisks indicate statistically significant differences 
between mutants and the wild type. *p ≤ 0.05; **p ≤ 0.01, unpaired 
t-test. b Relative viability of HT-29/B6 cells after infection was 
measured after 5 h and 24 h of infection and calculated as ratio 
of number of viable cells compared to the total cell numbers and 
normalised on the viability of uninfected control group. Values are 
the mean ± SD of three individual experiments. c Fold changes of IL-6 
and IL-8 mRNA expression were calculated relatively to non-infected 
controls and normalized to housekeeper. Experiments were 
performed in triplicate and the mean ± SD is presented. Only altered 
mRNA expression level above or below the dotted lines are defined 
as regulated. Asterisks indicate statistically significant differences 
between tested strains and negative controls at each time point. 
*p ≤ 0.05; **p ≤ 0.01; ***p≤ 0.001, unpaired t-test
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a decrease until 24 h p.i. in a similar manner. Although 
individual mRNA patterns of IL-6 have been observed 
during the infection of all strains, no significant differ-
ences were observed.
Discussions
Growing evidence has shown that adhesion and inva-
sion is mediated by multiple factors that are critical for 
pathogenesis of Campylobacter [1, 4, 5, 11]. However, 
the molecular mechanisms of pathogenicity are not fully 
understood. To continue identifying unknown virulence 
genes, a transposon mutant library of C. jejuni NCTC 
11168 was constructed and the ability of individual 
mutants to adhere to and invade human intestinal epi-
thelial cells was evaluated compared to the wild type. 
We identified two mutants of C. jejuni possessing altered 
phenotypes with transposon insertions in the genes 
Cj1492c and Cj1507c.
Gene Cj1492c, annotated as a two-component sensor 
belongs to the class of Per-Arnt-Sim motif (PAS) domain-
containing sensor histidine kinases, for which binding of 
a chemically diverse range of small-molecule metabolites 
is typical [31, 32]. It has been reported that mutagenesis 
of gene Cjj1484 (the orthologue of Cj1492c in C. jejuni 
81–176) was accompanied with the repression of several 
genes involved in metabolism, iron/heme acquisition and 
respiration during cultivation in broth, while no influence 
on colonisation of chickens was determined [33]. Oth-
ers have reported that the expression of Cj1492c was up-
regulated after treatment with 0.1% sodium deoxycholate 
and down-regulated after treatment with epinephrine 
and norepinephrine [34, 35]. However, neither the spe-
cific signalling molecule nor the function have yet been 
clarified.
The gene Cj1507c is annotated as a regulatory protein 
belonging to the family of LysR transcriptional regulators 
[22]. But little is known about the functions of LysR fam-
ily regulators in Campylobacter. Another LysR regulator 
(Cj1000) is reported to facilitate adaption of C. jejuni to 
host colonisation and respiration [36]. Taveirne et al. [22] 
described that Cj1507c is involved in the repression of the 
molybdenum transport system modABC as well as the 
tungsten transport system tunABC and therefore termed 
as modE [22]. In contrast to other ModE proteins, the C. 
jejuni ModE does not contain a metal binding domain but 
instead a protein–protein binding site. This indicates that 
ModE could be a DNA-binding subunit of a multiprotein 
complex involved in the repression of both transport sys-
tem operons [22]. Additionally, it has been reported that 
molybdenum plays an important role during intestinal 
colonisation of mice by C. jejuni 81-176 [37].
Previous studies determined that C. jejuni motil-
ity is necessary for colonising the mucous layer of the 
gastrointestinal tract and therefore is important for C. 
jejuni invasion of epithelial cells [1, 4, 5, 8, 18, 38]. The 
roles of motility, adhesion, invasion or their mutual 
interplay during pathogenesis have been partially clari-
fied. It is worth noting that both mutants ::Cj1492c and 
::Cj1507c retain slightly reduced motility but behave 
in a reverse manner in terms of adhesion and invasion. 
While mutagenesis of Cj1507c caused a severe reduction 
in adhesion and invasion, the disruption of Cj1492c con-
tributed to a significantly enhanced adhesion and inva-
sion. Therefore, it seems unlikely that the slightly reduced 
motility is the reason for the divergent effects observed 
for both mutants.
Furthermore, genes involved in intracellular sur-
vival have been reported to be also involved in invasion 
[18, 39]. In order to detect whether mutations of genes 
Cj1492c and Cj1507c caused altered intracellular sur-
vival, we determined the CFU of intracellular C. jejuni 
after 5 and 24 h p.i.. In our experiments, the amount of 
culturable intracellular bacteria was severely decreased 
after 24  h for both mutants and wild type. An accentu-
ated difference (one-tenth) in the survival rate between 
::Cj1507c and the wild type was found and ::Cj1492c 
showed intermediate survival (one-half ) compared to the 
wild type. Survival mechanisms of C. jejuni in eukaryotic 
cells are still not fully understood. It has been reported 
that C. jejuni undergoes intracellular metabolic repro-
gramming upon internalisation contributing to sub-
sequently impaired intracellular persistence [40, 41]. 
Hence, we assume that both genes Cj1492c and Cj1507c 
are also involved in the physiological adaptation of C. 
jejuni to the hostile intracellular environment.
Numerous cytotoxins produced by C. jejuni might 
be engaged in infection of host cells. Therefore, we 
addressed potential correlations between adhesion and 
invasion along with the impact of tested strains on host 
cell survival in HT-29/B6 cells after infection. In fact, 
we observed that there was a small but non-signifi-
cant decline in the number of viable host cells between 
infected and non-infected samples. However, no differ-
ence was found among wild type and two mutants nei-
ther at 5 nor at 24 h p.i.. As the wild type did not impair 
host cell viability in the time course of our experiments, 
which might be due to the short period of infection, we 
cannot exclude potential effects of mutations on host cell 
cytotoxicity upon infection at later time points.
Similarly, to what had been previously published, we 
observed significantly enhanced levels of IL-8 mRNA in 
all infected samples compared to the non-infected con-
trols [42–44]. After an early peak, there was a decrease in 
expression of IL-8, which agrees with previous observa-
tions regarding a down-regulation of pro-inflammatory 
cytokines after early peak to protect epithelial cells from 
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chronic inflammation and epithelial destruction [11]. 
We found that IL-8 expression in response to infection 
was similar among tested strains throughout the infec-
tion course. These data suggest that genes Cj1492c and 
Cj1507c are not responsible for the induction of IL-8 
expression in host cells. Furthermore, the IL-8 mRNA 
induction in our experiments appears to be independ-
ent from capabilities to adhere and to invade host cells 
or the intracellular persistence. No significant regulation 
of IL-6 mRNA expression was induced by both mutants 
and wild type along the entire infection course. Accord-
ing to a previous study, IL-8 is important for extracellular 
response, whereas IL-6 is considered as an important fac-
tor for integrity of epithelial cells and plays a vital role on 
the intracellular response [45].
The strategies of C. jejuni to invade epithelial cells are 
known as paracellular- and transcellular-pathways [7, 8]. 
In our immunofluorescent detection, several C. jejuni 
seemed to be located in the intercellular spaces. This 
might indicate that C. jejuni paracellularly transmigrate 
via cell junctions and then invade the epithelial cells 
at the basolateral membrane, since the CadF and FlpA 
binding-protein fibronectin is predominantly located on 
the basal site of enterocytes [9]. However, by the method 
applied in our study, we could not exactly distinguish 
whether the transmigration of tested strains and the 
infection of HT-29/B6 cells occurred via the trans- or 
paracellular pathway.
The observed phenotypical differences of mutants 
might also result from polar effects of the mutation. 
For the downstream located cognate response regula-
tor of the two-component sensor Cj1492c, it has been 
reported that it influences expression of some specific 
genes independently of the histidine kinase Cjj1484 [33]. 
The gene upstream of Cj1492c encodes an integral mem-
brane protein, containing a conserved protein domain 
of the possible sulfite exporter TauE/SafE family, which 
has not been well characterised in C. jejuni thus far. The 
downstream gene of Cj1507c encodes the chemoreceptor 
Tlp1, responsible for sensing aspartate [46], and muta-
tion of tlp1 resulted in enhanced adhesion and invasion 
of CaCo2 cells [47]. The gene fdhD, located upstream of 
Cj1507c, encodes an accessory protein of the formate 
dehydrogenase, which also has not been well investigated 
in C. jejuni. However, it has been demonstrated that 
mutation of fdhD resulted in similar colonisation abilities 
but reduced immunopathological responses in mice [48]. 
Nevertheless, it still remains unclear whether potential 
polar effects generated by mutagenesis of Cj1492c and 
Cj1507c play a role or not.
Conclusion
We conclude that genes regulated by Cj1507c have an 
impact on efficient adhesion, invasion and intracellular 
survival of C. jejuni in HT-29/B6 cells. Furthermore, sig-
nal sensing by Cj1492c seems to lead to limiting attach-
ment and hence internalisation of C. jejuni. However, as 
the intracellular survival capacities are reduced, we sug-
gest that signal sensing by Cj1492c may impact several 
processes related to pathogenicity of C. jejuni in HT-29/
B6 cells. A more complete understanding of the function 
of Cj1492c and Cj1507c as well as the regulatory net-
works is subject of our future investigations.
Methods
Bacterial strains and culture conditions
All bacterial strains used in this study (C. jejuni NCTC 
11168 and mutants ::Cj1492c, ::Cj1507c and ::flaA) 
were routinely grown on Mueller–Hinton agar (Oxoid, 
Munich, Germany) supplemented with 5% defibrinated 
sheep blood (MHA) or in Brucella broth (BB; BD, Heidel-
berg, Germany) at 37 ℃ under microaerobic conditions 
(10%  CO2, 6%  O2 and 85%  N2) generated by an Anoxomat 
(Omni Life Science, Bremen, Germany) as described pre-
viously [49]. For invasion, adhesion and infection assays, 
C. jejuni strains were grown to mid-exponential phase 
(approx. 20 h) in BB at 37 °C under microaerobic condi-
tions and harvested by centrifugation (14,000g, 5  min). 
Cell pellets were resuspended in appropriate buffers or 
media for further experiments. All in  vitro infections 
with bacteria were performed at a multiplicity of infec-
tion (MOI) of 500.
Random transposon mutagenesis
Campylobacter jejuni NCTC 11168 (wild type) was 
incubated for 24  h in BB at 37 ℃ under microaerobic 
conditions. DNA was extracted from this culture with 
Easy-DNA-Extraction kit (Invitrogen, Thermo Fisher 
Scientific, Waltham, US) according to manufacturer’s 
instructions. The extracted DNA was used for further 
insertion of HyperMu <KAN1> transposon (Epicentre, 
Madison, US). Briefly, a total volume of 40  µl contain-
ing 5 µg DNA, 1× reaction buffer, 50 ng Transposon and 
2 U Transposase were incubated for 2 h at 37 ℃. Reac-
tion was stopped by adding the stop solution and incu-
bation at 70 ℃ for 10 min and was stored at − 20 ℃ for 
further use. Wild type was mutated by natural transfor-
mation. In brief, C. jejuni NCTC 11168 was incubated in 
BB for 24 h at 37 ℃ under microaerobic conditions and 
diluted to  OD600 = 0.1. MHA in glass tubes was overlaid 
with 0.5  ml of this culture and incubated for 3  h. After 
addition of 5 µg genomic DNA with integrated transpo-
sons, the culture was further incubated for 20 h at 37 ℃ 
under microaerobic conditions. This culture was streaked 
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on MHA plates containing 20 µg/ml Kanamycin (Sigma-
Aldrich, St. Louis, MO, USA) and incubated for 72 h to 
select transformants. Each grown colony was enriched by 
48 h incubation on MHA containing 50 µg/ml Kanamy-
cin. Insertion site was determined by sequencing with the 
primers included in the HyperMu <KAN> Transposon 
Kit and further verified by PCR amplification with gene 
specific primers. All primers used in this study are listed 
in Table 1.
Primers used for partial amplification were designed 
with Primer3 version 0.4.0 [50] based on whole-genome 
sequence of C. jejuni NCTC 11168 [32]. To verify the 
mutated genes 0.4  µM of each primer, 1× PCR buffer 
(Qiagen, Hilden, Germany), 1.5  mM  MgCl2 (Qiagen), 
0.4  mM of each dNTPs (Fermentas, St. Leon-Rot, Ger-
many), 0.5 U Taq-Polymerase (Qiagen) and 2 µl extracted 
genomic DNA of each mutant were used in PCR. The fol-
lowing amplification protocol was used: initial denatura-
tion for 5 min at 95 ℃ followed by 35 cycles with 30 s at 
94 ℃, 60 s at 59 ℃ and 60 s at 72 ℃. Afterwards, a final 
elongation step was performed for 7  min at 72 ℃. PCR 
amplification products were separated by 1.5% agarose 
gel-electrophoresis and fragment size was determined 
according to the Hyperladder 1 kb Plus (Bioline, Lucken-
walde, Germany) standards.
Growth curve
Growth curves of wild type, ::Cj1492c and ::Cj1507c were 
generated as previously described with few modifications 
[49]. Briefly, 5 ml BB was inoculated with freshly grown 
bacteria of each strain and incubated overnight (approxi-
mately 18  h) at 37 ℃ under microaerobic conditions. 
These pre-cultures were diluted in BB to reach a starting 
culture with approximately 6 × 103  CFU/ml and incu-
bated at 37 ℃ for 48  h under microaerobic conditions. 
Viable bacterial numbers were determined at indicated 
time points by plating serial dilutions  (10−1) on MHA 
plates. Before determining the CFU, plates were incu-
bated at 37 ℃ under microaerobic conditions for 48  h. 
Experiments were repeated independently at least three 
times and CFU/ml was determined in duplicate.
Swarming assay
Swarming assays were performed according to previous 
studies [6, 49] with some modifications. The wild type 
and the mutant strains (::flaA, ::Cj1492c, ::Cj1507c) were 
cultured in BB for 20 h at 37 °C under microaerobic con-
ditions and adjusted to 1 × 108 CFU/ml. 1 μl of each over-
night culture was stabbed into Mueller–Hinton plates 
containing 0.4% agar (MH)  and incubated microaerobi-
cally at 37 ℃ for 24  h. To minimise plate-to-plate vari-
ations, all tested mutant strains and the wild type were 
included on the same agar plate. The diameter of formed 
halo of the mutants was measured and normalised to the 
wild type from the same plate. Each strain was analysed 
performing at least five independent assays.
Cultivation of human epithelial cells
The sub clone HT-29/B6 [19] of the human colorectal 
adenocarcinoma cell line HT-29 (DSMZ_ACC 299) was 
routinely cultured as described previously [51]. Briefly, 
HT-29/B6 cells were cultured in RPMI 1640 medium 
(Lonza, Basel, Switzerland) supplemented with 10% (v/v) 
Table 1 Primers used in this study
Gene Primer Sequence
Cj1492c Cj1492c_fw TTT GAT TGT GAG TAA ATT TCA GCA A
Cj1492c_rev ATG CAA ATT GCC TTG GAA AA
Cj1507c Cj1507c_fw TCG GCT AAT TGT CCG ATT TT
Cj1507c_rev CGC TTT GTG GTT TTG CTA GA
flaA flaA_fw ACG ATA TAG CAT TTA ACA AG
flaA_rev AAC AAC TGA ATT TGC ATG TGC 
Transposon MUKAN-1 FP-1 forward primer CTG GTC CAC CTA CAA CAA AGG 
MUKAN-1 RP-1 reverse primer AGA GAT TTT GAG ACA GGA TCC G
IL-6 hsa_IL6_fw GAA AGC AGC AAA GAG GCA CT
hsa_IL6_rev TTT TCA CCA GGC AAG TCT CC
IL-8 hsa_IL8_fw GTG CAG TTT TGC CAA GGA GT
hsa_IL8_rev CTC TGC ACC CAG TTT TCC TT
ACTB hsa_ACTB_fw GGA CTT CGA GCA AGA GAT GG
hsa_ACTB_rev AGC ACT GTG TTG GCG TAC AG
B2M hsa_B2M_fw GTG CTC GCG CTA CTC TCT CT
hsa_B2M_rev GGA TGG ATG AAA CCC AGA CA
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FCS superior (Biochrom, Cambridge, United Kingdom) 
in 75 cm2 tissue culture flasks (Sarstedt, Nümbrecht, Ger-
many) at 37 ℃ and 5%  CO2 under a humidified atmos-
phere until a confluence of approx. 80–90% was reached. 
For adhesion and invasion assays, 1 × 105 HT-29/B6 cells 
were seeded into each well of a 24 well plate (Sarstedt) 
and incubated for 7  days changing the media every 
3 days. For examining cytotoxicity, each well of a 96 well 
plate (Sarstedt) was seeded with 1.8 × 104 HT-29/B6 cells 
and incubated as described above. For gene expression 
analysis, infection assays were performed in 6 well plates 
(Sarstedt) with 5 × 105 HT-29/B6 cells seeded per well 
and following incubation at 37 ℃ and 5%  CO2 routinely 
changing the medium for 7 days.
In vitro adhesion and invasion assay
Adhesion and invasion assays with the cell line HT-29/B6 
were performed with wild type, ::Cj1492c and ::Cj1507c 
as previously described with slight modification [51, 
52]. Briefly, approximately 1 × 105 HT-29/B6 cells were 
seeded into each well of a 24 well plate. After 7 days of 
differentiation, cells with ~ 80–90% confluence were 
infected with a suspension of approximately 1 × 109 CFU 
of bacteria (MOI 500) for both adhesion and invasion 
assays. To determine the adhesion of each strain, mon-
olayers were infected for 1 h and incubated at 37 ℃ with 
5%  CO2. Afterwards, infected cells were rinsed with 
phosphate buffered saline (PBS, Sigma-Aldrich) to wash 
off loosely attached C. jejuni and then lysed with 1% Tri-
ton-X-100 (Carl Roth, Karlsruhe, Germany) for 10  min 
at room temperature. For invasion assays, infected mon-
olayers were incubated for 3 h and subsequently treated 
with 300  ng/ml gentamicin for 2  h (Biochrom) to kill 
extracellular bacteria. Following additional washes with 
PBS, cells were lysed as described above. To evaluate 
numbers of adherent or invasive bacteria, C. jejuni from 
respective lysates were serially diluted and CFU counted 
on MHA after 48 h incubation at 37 ℃ under microaero-
bic conditions. Adhesion and invasion index were calcu-
lated as percentage of the inoculum, respectively. Each 
experiment was performed using at least three biological 
replicates considering three technical replicates for each.
Immunofluorescence detection and microscopy
HT-29/B6 cells were grown on 8-well chamber slides 
(Sarstedt) to ~ 80–90% confluence and then infected with 
::Cj1492c, ::Cj1507c and the wild type (MOI 500) for 3 h 
and subsequently treated with gentamicin as described 
above. After incubation, the slides were washed three 
times with PBS and fixed in 3.7% formaldehyde at room 
temperature for 15 min. Fixed cells were washed with PBS 
three times and permeabilised with 0.25% Triton X-100 
for 15 min at room temperature followed by three wash-
ing steps with PBS. Non-specific binding was blocked 
with Endogenous Avidin/Biotin blocking kit (Abcam, 
Cambridge, United Kingdom) according to the manu-
facturer’s protocol followed by incubation in 1% bovine 
serum albumin (Sigma-Aldrich) in PBST (PBS + 1% 
Tween 20) for 1 h at room temperature. Cells were subse-
quently incubated with 1:1000 diluted primary antibody 
for C. jejuni (Biotin-rabbit polyclonal, Abcam) in PBST 
supplemented with 1% BSA in a humidified chamber 
overnight at 4 ℃. After three washes with PBS for 5 min, 
primary antibody was visualised using Alexa Fluor 488 
conjugated streptavidin (1:400 diluted) (Thermo Fisher 
Scientific) following the method previously described 
with slight modifications [21]. HT-29/B6 cell membranes 
were subsequently stained with wheat germ agglutinin 
conjugate WGA-CF®594 (Biotium, Fremont, US) at a 
concentration of 5  µg/ml in Hank’s Balanced Salt Solu-
tion (HBSS; Lonza) for 10 min at room temperature, fol-
lowed by washing twice in PBS. Nuclei were stained with 
DAPI (200 ng/ml) (Sigma) by 15 min incubation at room 
temperature. After two washes with PBS, the slides were 
mounted with 50% glycerol in PBS before fluorescence 
microscopy using a Leica DMI6000 (Leica, Wetzlar, Ger-
many). The internalisation level of tested strains was cal-
culated as a ratio of invaded C. jejuni and infected host 
cells, which were automatically counted by the ImageJ 
software as previously described [27]. Briefly, we used 
ImageJ to outline interested signals by thresholding and 
then identified particles with a specific size range. After-
wards, the particle counting was automatically measured 
by the Region of Interest (RoI) manager.
Cell viability determination
To study effects of C. jejuni on HT-29/B6 viability, Cal-
cein-acetoxymethyl/Hoechst staining was performed. 
Calcein-acetoxymethyl (Calcein-AM; Biotium) has 
already been described as a green fluorescent indica-
tor of viable cells in cytotoxicity assays [29, 30]. Hoechst 
33342 (Thermo Fisher Scientific) (hereinafter referred to 
as Hoechst) is used as a blue fluorescent marker of the 
nuclei of all cells [53]. Viability of HT-29/B6 cells was 
investigated in 96 well plates (Sarstedt). After 7 days dif-
ferentiation, HT-29/B6 with ~ 80–90% confluence were 
infected with wild type, ::Cj1492c and ::Cj1507c for 5  h 
and 24 h as described before. Infected monolayers were 
washed 3 times with PBS and incubated with 0.4  µM 
Calcein-AM at 37 ℃ with 5%  CO2 for 30  min. 5  µg/ml 
Hoechst was added to each well and incubated 15  min 
at room temperature followed by two washes with PBS. 
Fluorescence micrographs were subsequently captured 
with a Leica DMI6000 (Leica). The relative viability of 
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host cells was calculated as percentage of the number of 
viable cells compared to the total cell numbers automati-
cally determined using the ImageJ software as described 
above [27]. Presented results are calculated from three 
individual assays.
RNA isolation and RT‑qPCR
For mRNA expression analysis, in vitro infection was per-
formed as described above and HT-29/B6 samples were 
taken at 1, 5 and 24 h p.i. considering respective negative 
controls (non-infected cells). For this, cell monolayers 
were washed three times with PBS and lysed directly in 
each well of 8-well plates by addition of cell lysis buffer 
(Roboklon, Berlin, Germany). Total RNA was isolated 
with Universal RNA/miRNA Purification Kit (Roboklon) 
according to the manufacturer’s protocol. The RNA qual-
ity and quantity was controlled using the Agilent 2100 
Bioanalyzer with the RNA Nano Chips (Agilent, Wald-
bronn, Germany) and the DS-11 Spectrophotometer/
Fluorometer (DeNovix Inc., Wilmington, USA), respec-
tively. Relative expression of mRNA coding for IL-6 and 
IL-8 was quantified by RT-qPCR as described earlier [54]. 
For normalisation of gene expression, ACTB and B2M 
transcripts were used as reference genes and relative gene 
expression was calculated as described earlier [54] by the 
∆∆Ct method [55]. Experiments were performed in trip-
licate. Primers used in this study are listed in Table 1.
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